Citadel Advisors »

Hcw Biologics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Hcw Biologics (HCWB) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Hcw Biologics

Tip: Access up to 7 years of quarterly data

All positions including Hcw Biologics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hcw Biologics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $13k 10k 1.23

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Hcw Biologics

HighTower Advisors
Honkamp Krueger Financial Services
Pullen Investment Management
BlackRock
Vanguard Group
AE Wealth Management
Two Sigma Investments
Citadel Advisors
UBS Group
Royal Bank of Canada
Wells Fargo & Company
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Hcw Biologics